FDA Inspection
Mayo Clinic Health System MankatoMayo Clinic Health System Mankato – FDA Inspection, Aug 16, 2016
Record Details
This FDA Inspection record concerns Mayo Clinic Health System Mankato, with an inspection on August 16, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 16, 2016
- Product Type
- Biologics
View Company Profile
ID · c39611bf-a0c3-4899-93de-1a27feb5822e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 982406
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Mayo Clinic Health System Mankato
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 28, 2026 | Not classified | Minneapolis District Office | |
| February 11, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 22, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Mayo Clinic Health System Mankato
- FDA Inspection 1304402 - 2026-01-28
- FDA Inspection 1121192 - 2020-02-11
- FDA Inspection 1057119 - 2018-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.